Cited by 515Birth, Development, and HealthEpigenetics and DNA MethylationGestational Diabetes Research and Management

Cohort Profile: Growing Up in Singapore Towards healthy Outcomes (GUSTO) birth cohort study

Soh, S.-E., Tint, M. T., Gluckman, P. D., Godfrey, K. M., Rifkin-Graboi, A., Chan, Y. H., Stunkel, W., Holbrook, J. D. +67 more·2014·International Journal of Epidemiology

Abstract

Modern lifestyles and nutritional transition have given rise to an emerging epidemic of obesity and type 2 diabetes in developed and developing countries.1,2 In general, metabolic compromise is seen in South Asians at relatively lower levels of obesity compared with Europeans, with Chinese having an intermediate relationship, suggesting that the patterns of development of obesity and metabolic function in different Asian populations merits focused investigation.3 The prevalence of type 2 diabetes in Singapore has increased from 1.9% in 1975 to 11.2% in 2010, and is now one of the highest in the developed world.4 The three major Singaporean ethnic groups, Chinese, Malays and Indians, appear to have distinct susceptibilities leading to differing metabolic risk.5 Such differences may be genetic, developmental or cultural in origin. The pathways leading to insulin resistance, obesity and related traits are complex and derive from an interplay of genomic and environmental factors operating over the lifespan, including during early development.6 Environmental cues such as maternal nutrition can have important effects on foetal gene expression and have been shown to influence developmental plasticity7 via epigenetic processes.8 In recent years, major epigenetic pathways involving histone and DNA modifications have been unravelled and more technological tools developed to study their function.9,10 It has recently been reported that it may be of value to measure epigenetic changes in DNA derived from foetal tissues at birth, such as umbilical cord.11 Hence, we wished to examine whether specific epigenetic marks have utility as biomarkers for identifying babies that are ‘programmed’ in utero to develop obesity or non-communicable diseases later in life.11,12 A set of epigenetic biomarkers would allow clinical intervention at early stages in individuals at risk, thereby enabling prevention of obesity and metabolic diseases.13

Integrity signals

Registry

Crossref · 10.1093/ije/dyt125

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Soh, S.-E., Tint, M. T., Gluckman, P. D., Godfrey, K. M., Rifkin-Graboi, A., Chan, Y. H., Stunkel, W., Holbrook, J. D., Kwek, K., Chong, Y.-S., Saw, S. M., the GUSTO Study Group, Sheppard, A., Chinnadurai, A., Ferguson-Smith, A., Goh, A. E. N., Biswas, A., Chia, A., Leutscher-Broekman, B., Shuter, B., Cai, S., Ngo, C., Chng, C. K., Chong, S. C., Henry, C. J., Chua, M. C., Chee, C. Y. I., Goh, Y. T. D., Bier, D., Ding, C. M., Fok, D., Finkelstein, E. A., Yap, F. K. P., Yeo, G. S. H., Han, W. M., Chen, H., Van Bever, H. P. S., Inskip, H., Magiati, I., Wong, I. B. Y., Kapur, J., Richmond, J. L., Chan, J. K. Y., Gooley, J. J., Niduvaje, K., Lee, B. W., Lee, Y. S., Singh, L., Lim, S. B., Daniel, L. M., Loh, S. F., Low, Y.-L., Shek, P.-C. L., Fortier, M., Hanson, M., Chong, M. F.-F., Meaney, M., Morton, S., Pang, W. W., Agarwal, P., Qiu, A., Quah, B. L., van Dam, R. M., Stringer, D., Rebello, S. A., So, W. C., Hsu, C.-Y., Su, L. L., Tang, J., Tan, K. H., Tan, S. H., Teoh, O. H., Rajadurai, V. S., Wong, P., & Venkatesh, S. K.
Affiliations
  • Agency for Science, Technology and Research (SG)
  • National University of Singapore (SG)
  • National University Health System (SG)
Corresponding author
Saw, S. M.
Venue
International Journal of Epidemiology
Published
2013-08-02
Volume
43
Issue
5
Pages
1401-1409
ISSN
  • 0300-5771 (ISSN-L)
  • 1464-3685
OpenAlex
W2108343924
Cited by
515
References
2
Citations by year
2026: 36 · 2025: 43 · 2024: 59 · 2023: 33 · 2022: 47 · 2021: 60 · 2020: 37 · 2019: 34 · 2018: 30 · 2017: 50 · 2016: 34 · 2015: 36 · 2014: 14 · 2013: 2
FWCI
26.76
Type
journal article
Language
en
Open access
closed
Locations
  • International Journal of Epidemiology (publishedVersion)
  • PubMed (publishedVersion)
  • National University of Singapore (submittedVersion)
Funders
  • National Research Foundation
  • Medical Research Council (MC_UU_12011/4)
  • National Medical Research Council
Topics
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
Keywords
Singapore, childhood obesity, type 2 diabetes, epigenetic biomarkers, maternal nutrition, developmental programming, insulin resistance, non-communicable diseases
MeSH terms
Adolescent, Adult, Female, Gestational Age, Humans, Male, Middle Aged, Pregnancy, Prenatal Exposure Delayed Effects, Singapore, Cohort Studies, Epigenesis, Genetic, Fetal Development

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review